LONDON, March 14, 2012 /PRNewswire/ --
Pharma IQ has just published the results of an industry-wide Compound Management Survey, conducted recently among 4,000 compound management specialist with nearly half of those questioned having a library or sample management team responsible for biological materials or samples.
According to the survey results, 66.7 per cent of the professionals in the field cited three areas as primary concerns in their current role or department: the quality of samples, which can deteriorate during transport, the management of sample data and the huge need to construct new libraries to meet their new research.
With regard to the biggest challenges in handling biological samples or materials, the study revealed that quality perseverance, safeguarding of sample quality as well introducing an effective ID and tracking system was their key priority.
The survey was created as a part of the pre-conference research for Compound and Sample Management Forum taking place 21-23 May, 2012 in Amsterdam.
The results helped to shape the agenda and final speaker line-up which features Stuart Ratcliffe, Senior Scientist (Projects), Screening Sciences & Sample Management from AstraZeneca explaining the Automation in Compound Management employed at Astra Zeneca and Ling Santora, Senior Scientist, Bioresearch Centre from Abbott leading a session on The Biologics Pharmacy - Ensuring High Quality of Protein Reagents to Support Biologics Drug Discovery and Research at Abbott.
Other important topics expressed by survey respondents that will be discussed at the event include:
- Management of in-vitro synthesized and in-vivo RNAi Reagents at the Drosophila RNAi Screening (Stephanie Mohr PhD, Director of the Drosophila RNAi Screening Center, Harvard Medical School)
- Sample management workflows and supporting software (Janet Diratsaoglu, Principal Scientist, Roche)
- Building a cDNA and RNAi library management system (Karen Billeci Scientific Manager, Assay & Automation Technology Group Genentech)
- Library strategies: A model for academic/industrial collaboration in drug discovery: the rare paediatric brain tumour campaign at St. Jude Children's Research Hospital (Anang Shelat, Director, Lead Discovery Informatics and Compound Management, Department of Chemical Biology and Therapeutics
St. Jude Children's Research Hospital)
Media contact: Joanna, +44(0)20-7368-9421, [email protected] - Please contact for more information or images.
Press are invited to attend this important industry forum, if you would like to a complimentary press pass please email Joanna Checinska ([email protected])
SOURCE Pharma IQ